自1957年合成灭滴灵以来,在国内现有的药典中,均将它分编在“抗寄生虫药物”的章节中。过去,人们只用它来治疗阴道滴虫病、阿米巴原虫感染及梨形鞭毛虫病等。1962年,国外发现该药亦有抗致病性厌氧菌作用,1978年被世界卫生组织确定为抗厌氧菌感染的首选药物,1982年又因梅·贝克公司的潜心研究,用于手术后抗厌氧菌感染取得成 Since the synthesis of metronidazole in 1957, it has been codified in the existing “Pharmacopoeia” in the chapter “Anti-parasitic drugs.” In the past, people only used it for the treatment of vaginal trichomoniasis, amoeba protozoa infection and flagellosis. In 1962, the drug was also found to have anti-pathogenic anaerobic effect in foreign countries. In 1978, it was identified as the drug of choice for anti-anaerobic infections by the World Health Organization. In 1982, due to the painstaking research by Mei Beike Company, it was used for anti-anaerobic infections after surgery Get into